Home > Publications Database > The Greifswald Post COVID Rehabilitation Study and Research (PoCoRe)-Study Design, Characteristics and Evaluation Tools. > print |
001 | 194978 | ||
005 | 20231004134621.0 | ||
024 | 7 | _ | |a 10.3390/jcm12020624 |2 doi |
024 | 7 | _ | |a pmid:36675551 |2 pmid |
024 | 7 | _ | |a pmc:PMC9861069 |2 pmc |
024 | 7 | _ | |a altmetric:141145135 |2 altmetric |
037 | _ | _ | |a DZNE-2023-00165 |
041 | _ | _ | |a English |
082 | _ | _ | |a 610 |
100 | 1 | _ | |a Steinmetz, Anke |0 0000-0002-7118-3372 |b 0 |
245 | _ | _ | |a The Greifswald Post COVID Rehabilitation Study and Research (PoCoRe)-Study Design, Characteristics and Evaluation Tools. |
260 | _ | _ | |a Basel |c 2023 |b MDPI |
336 | 7 | _ | |a article |2 DRIVER |
336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1678103969_13062 |2 PUB:(DE-HGF) |
336 | 7 | _ | |a ARTICLE |2 BibTeX |
336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
520 | _ | _ | |a (1) Background: COVID-19 is often associated with significant long-term symptoms and disability, i.e., the long/post-COVID syndrome (PCS). Even after presumably mild COVID-19 infections, an increasing number of patients seek medical help for these long-term sequelae, which can affect various organ systems. The pathogenesis of PCS is not yet understood. Therapy has so far been limited to symptomatic treatment. The Greifswald Post COVID Rehabilitation Study (PoCoRe) aims to follow and deeply phenotype outpatients with PCS in the long term, taking a holistic and comprehensive approach to the analysis of their symptoms, signs and biomarkers. (2) Methods: Post-COVID outpatients are screened for symptoms in different organ systems with a standardized medical history, clinical examination, various questionnaires as well as physical and cardiopulmonary function tests. In addition, biomaterials are collected for the analysis of immunomodulators, cytokines, chemokines, proteome patterns as well as specific (auto)antibodies. Patients are treated according to their individual needs, adhering to the current standard of care. PoCoRe's overall aim is to optimize diagnostics and therapy in PCS patients. |
536 | _ | _ | |a 899 - ohne Topic (POF4-899) |0 G:(DE-HGF)POF4-899 |c POF4-899 |f POF IV |x 0 |
588 | _ | _ | |a Dataset connected to CrossRef, PubMed, , Journals: pub.dzne.de |
650 | _ | 7 | |a 6-min-walk-test |2 Other |
650 | _ | 7 | |a after-care |2 Other |
650 | _ | 7 | |a biobanking |2 Other |
650 | _ | 7 | |a cardiopulmonary function |2 Other |
650 | _ | 7 | |a cognitive function |2 Other |
650 | _ | 7 | |a non-hospitalized patients |2 Other |
650 | _ | 7 | |a post-COVID syndrome |2 Other |
650 | _ | 7 | |a psychological profile |2 Other |
650 | _ | 7 | |a rehabilitation |2 Other |
700 | 1 | _ | |a Bahlmann, Susanne |b 1 |
700 | 1 | _ | |a Bergelt, Corinna |0 0000-0003-1413-1872 |b 2 |
700 | 1 | _ | |a Bröker, Barbara M |b 3 |
700 | 1 | _ | |a Ewert, Ralf |0 0000-0002-6746-9925 |b 4 |
700 | 1 | _ | |a Felix, Stephan B |b 5 |
700 | 1 | _ | |a Flöel, Agnes |0 P:(DE-2719)2812683 |b 6 |u dzne |
700 | 1 | _ | |a Fleischmann, Robert |0 0000-0001-8159-2658 |b 7 |
700 | 1 | _ | |a Hoffmann, Wolfgang |0 P:(DE-2719)2000040 |b 8 |u dzne |
700 | 1 | _ | |a Holtfreter, Silva |0 0000-0002-2672-8230 |b 9 |
700 | 1 | _ | |a Nauck, Matthias |0 0000-0002-6678-7964 |b 10 |
700 | 1 | _ | |a Riemann, Katja |b 11 |
700 | 1 | _ | |a Scheer, Christian |0 0000-0001-6171-8874 |b 12 |
700 | 1 | _ | |a Stahl, Dana |b 13 |
700 | 1 | _ | |a Vogelgesang, Antje |0 0000-0003-2984-0831 |b 14 |
700 | 1 | _ | |a Völker, Uwe |0 P:(DE-HGF)0 |b 15 |
700 | 1 | _ | |a Wiesmann, Ulrich |b 16 |
700 | 1 | _ | |a Klinger-König, Johanna |0 0000-0003-2287-7914 |b 17 |
700 | 1 | _ | |a Walk, René |b 18 |
700 | 1 | _ | |a Grabe, Hans |0 P:(DE-2719)2811781 |b 19 |u dzne |
700 | 1 | _ | |a Gross, Stefan |0 0000-0003-4121-7161 |b 20 |
700 | 1 | _ | |a Lehnert, Kristin |0 0000-0003-2342-3949 |b 21 |
700 | 1 | _ | |a Fielitz, Jens |0 0000-0001-8522-1045 |b 22 |
700 | 1 | _ | |a Dörr, Marcus |0 0000-0001-7471-475X |b 23 |
773 | _ | _ | |a 10.3390/jcm12020624 |g Vol. 12, no. 2, p. 624 - |0 PERI:(DE-600)2662592-1 |n 2 |p 624 |t Journal of Clinical Medicine |v 12 |y 2023 |x 2077-0383 |
856 | 4 | _ | |y OpenAccess |u https://pub.dzne.de/record/194978/files/DZNE-2023-00165.pdf |
856 | 4 | _ | |y OpenAccess |x pdfa |u https://pub.dzne.de/record/194978/files/DZNE-2023-00165.pdf?subformat=pdfa |
909 | C | O | |o oai:pub.dzne.de:194978 |p openaire |p open_access |p VDB |p driver |p dnbdelivery |
910 | 1 | _ | |a External Institute |0 I:(DE-HGF)0 |k Extern |b 6 |6 P:(DE-2719)2812683 |
910 | 1 | _ | |a External Institute |0 I:(DE-HGF)0 |k Extern |b 8 |6 P:(DE-2719)2000040 |
910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 15 |6 P:(DE-HGF)0 |
910 | 1 | _ | |a External Institute |0 I:(DE-HGF)0 |k Extern |b 19 |6 P:(DE-2719)2811781 |
913 | 1 | _ | |a DE-HGF |b Programmungebundene Forschung |l ohne Programm |1 G:(DE-HGF)POF4-890 |0 G:(DE-HGF)POF4-899 |3 G:(DE-HGF)POF4 |2 G:(DE-HGF)POF4-800 |4 G:(DE-HGF)POF |v ohne Topic |x 0 |
914 | 1 | _ | |y 2023 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0160 |2 StatID |b Essential Science Indicators |d 2022-11-17 |
915 | _ | _ | |a Creative Commons Attribution CC BY 4.0 |0 LIC:(DE-HGF)CCBY4 |2 HGFVOC |
915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0113 |2 StatID |b Science Citation Index Expanded |d 2022-11-17 |
915 | _ | _ | |a Fees |0 StatID:(DE-HGF)0700 |2 StatID |d 2022-11-17 |
915 | _ | _ | |a OpenAccess |0 StatID:(DE-HGF)0510 |2 StatID |
915 | _ | _ | |a Article Processing Charges |0 StatID:(DE-HGF)0561 |2 StatID |d 2022-11-17 |
915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b J CLIN MED : 2022 |d 2023-08-25 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |d 2023-08-25 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |d 2023-08-25 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0320 |2 StatID |b PubMed Central |d 2023-08-25 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0501 |2 StatID |b DOAJ Seal |d 2023-04-12T14:59:21Z |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0500 |2 StatID |b DOAJ |d 2023-04-12T14:59:21Z |
915 | _ | _ | |a Peer Review |0 StatID:(DE-HGF)0030 |2 StatID |b DOAJ : Anonymous peer review |d 2023-04-12T14:59:21Z |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0600 |2 StatID |b Ebsco Academic Search |d 2023-08-25 |
915 | _ | _ | |a Peer Review |0 StatID:(DE-HGF)0030 |2 StatID |b ASC |d 2023-08-25 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |d 2023-08-25 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |d 2023-08-25 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1110 |2 StatID |b Current Contents - Clinical Medicine |d 2023-08-25 |
915 | _ | _ | |a IF < 5 |0 StatID:(DE-HGF)9900 |2 StatID |d 2023-08-25 |
920 | 1 | _ | |0 I:(DE-2719)6000017 |k Rostock / Greifswald common |l Rostock / Greifswald common |x 0 |
980 | _ | _ | |a journal |
980 | _ | _ | |a VDB |
980 | _ | _ | |a UNRESTRICTED |
980 | _ | _ | |a I:(DE-2719)6000017 |
980 | 1 | _ | |a FullTexts |
Library | Collection | CLSMajor | CLSMinor | Language | Author |
---|